Literature DB >> 9481791

Microfibrillar composition of umbilical cord matrix: characterization of fibrillin, collagen VI and intact collagen V.

S Franc1, J C Rousseau, R Garrone, M van der Rest, M Moradi-Améli.   

Abstract

Ultrastructural studies made on human umbilical cord revealed that the striated collagen fibrils of the Wharton's jelly matrix are mixed with many microfibrillar structures. Microfibrils were found with a tubular cross-section of 10-12 nm diameter and were organized as beaded filaments characteristic of fibrillin-rich microfibrils. Beads had an average diameter of 25 nm and were spaced at about 50-80 nm. This ultrastructural observation was confirmed by indirect immunofluorescent staining of the jelly matrix using monoclonal antibody to fibrillin. Another constituent of the microfibrillar network was present as typical 100-nm periodic filaments of type VI collagen. Indirect immunofluorescent staining using antibodies to collagen VI showed for the first time that this collagen appeared to be distributed largely in the jelly matrix. In addition, other microfibrils with no specific banding pattern were observed. These microfibrils may constitute an organization of type V collagen different from the one which is generally assembled in heterotypic fibrils with collagen I. Among the latter heterotypic fibrils, type V collagen was studied using an anti-peptide antibody to the most N-terminal non-collagenous region of its alpha 2(V) chain. This antibody recognized a filamentous mesh decorating the bundles of collagen fibrils by immunofluorescent staining. This indicates that at least this part of alpha 2(V) chain may be accessible to the antibody at the surface of the fibrils.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9481791     DOI: 10.1016/s0143-4004(98)90104-7

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  12 in total

1.  TGF-beta binding in human Wharton's jelly.

Authors:  Andrzej Małkowski; Krzysztof Sobolewski; Stefan Jaworski; Edward Bańkowski
Journal:  Mol Cell Biochem       Date:  2008-01-24       Impact factor: 3.396

2.  Lipid compounds of human Wharton's jelly and their alterations in preeclampsia.

Authors:  Lech Romanowicz; Edward Bańkowski
Journal:  Int J Exp Pathol       Date:  2009-10-28       Impact factor: 1.925

Review 3.  Preparation of placental tissue transplants and their application in skin wound healing and chosen skin bullous diseases - Stevens-Johnson syndrome and toxic epidermal necrolysis treatment.

Authors:  Agnieszka Klama-Baryła; Ewa Rojczyk; Diana Kitala; Wojciech Łabuś; Wojciech Smętek; Katarzyna Wilemska-Kucharzewska; Marek Kucharzewski
Journal:  Int Wound J       Date:  2020-01-15       Impact factor: 3.315

4.  Decellularized Wharton's Jelly from human umbilical cord as a novel 3D scaffolding material for tissue engineering applications.

Authors:  Sushma Jadalannagari; Gabriel Converse; Christopher McFall; Eric Buse; Michael Filla; Maria T Villar; Antonio Artigues; Adam J Mellot; Jinxi Wang; Michael S Detamore; Richard A Hopkins; Omar S Aljitawi
Journal:  PLoS One       Date:  2017-02-21       Impact factor: 3.240

5.  The Effect of Cryopreserved Human Placental Tissues on Biofilm Formation of Wound-Associated Pathogens.

Authors:  Yong Mao; Anya Singh-Varma; Tyler Hoffman; Sandeep Dhall; Alla Danilkovitch; Joachim Kohn
Journal:  J Funct Biomater       Date:  2018-01-08

6.  Antibacterial and Immunomodulatory Properties of Acellular Wharton's Jelly Matrix.

Authors:  Marie Dubus; Loïc Scomazzon; Julie Chevrier; Charlotte Ledouble; Adrien Baldit; Julien Braux; Florelle Gindraux; Camille Boulagnon; Sandra Audonnet; Marius Colin; Hassan Rammal; Cédric Mauprivez; Halima Kerdjoudj
Journal:  Biomedicines       Date:  2022-01-21

7.  Decellularization of Wharton's Jelly Increases Its Bioactivity and Antibacterial Properties.

Authors:  M Dubus; L Scomazzon; J Chevrier; A Montanede; A Baldit; C Terryn; F Quilès; C Thomachot-Schneider; S C Gangloff; N Bouland; F Gindraux; H Rammal; C Mauprivez; H Kerdjoudj
Journal:  Front Bioeng Biotechnol       Date:  2022-03-11

8.  Umbilical cord extracts improve osteoporotic abnormalities of bone marrow-derived mesenchymal stem cells and promote their therapeutic effects on ovariectomised rats.

Authors:  Akira Saito; Kanna Nagaishi; Kousuke Iba; Yuka Mizue; Takako Chikenji; Miho Otani; Masako Nakano; Kazusa Oyama; Toshihiko Yamashita; Mineko Fujimiya
Journal:  Sci Rep       Date:  2018-01-18       Impact factor: 4.379

9.  Fabrication and In Vitro Study of Tissue-Engineered Cartilage Scaffold Derived from Wharton's Jelly Extracellular Matrix.

Authors:  Tongguang Xiao; Weimin Guo; Mingxue Chen; Chunxiang Hao; Shuang Gao; Jingxiang Huang; Zhiguo Yuan; Yu Zhang; Mingjie Wang; Penghao Li; Jiang Peng; Aiyuan Wang; Yu Wang; Xiang Sui; Li Zhang; Wenjing Xu; Shibi Lu; Heyong Yin; Jianhua Yang; Shuyun Liu; Quanyi Guo
Journal:  Biomed Res Int       Date:  2017-10-29       Impact factor: 3.411

Review 10.  Human Wharton's Jelly-Cellular Specificity, Stemness Potency, Animal Models, and Current Application in Human Clinical Trials.

Authors:  Katarzyna Stefańska; Katarzyna Ożegowska; Greg Hutchings; Małgorzata Popis; Lisa Moncrieff; Claudia Dompe; Krzysztof Janowicz; Wojciech Pieńkowski; Paweł Gutaj; Jamil A Shibli; Walterson Mathias Prado; Hanna Piotrowska-Kempisty; Paul Mozdziak; Małgorzata Bruska; Maciej Zabel; Bartosz Kempisty; Michał Nowicki
Journal:  J Clin Med       Date:  2020-04-12       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.